Genna Jenkins has more than 8 years of experience in regulatory affairs. Genna’s experience spans USDA-BRS-APHIS, FDA-CDER, FDA-CBER, and FDA-Medical Devices across oncology, neurology, therapeutics, infectious disease, and transgenic organisms. Genna has early-phase experience across various product classes and late-stage oncology experience.

Prior to joining Halloran, Genna was the Director of Regulatory Affairs at Ventria Bioscience Inc., a biopharmaceutical developer and biomanufacturer, where she facilitated regulatory compliance, site inspections, managed existing early-phase submissions, authored CMC content, and provided project management and collaborative support both internally and externally for various cross-functional groups. In tandem with her regulatory and project management roles, Genna functioned as a Research Scientist in the Department of Molecular Biology where she participated in the development of recombinant proteins and antibodies, regeneration of transgenic organisms, and production of critical raw materials.

Education:
Kansas State University, Bachelor of Science, Political Science
Kansas State University, Master of Science, Plant Pathology